Skip to main content
    B

    Bio Green Med Solution, Inc. (BGMS)

    Official site

    INDUSTRIALS • BUILDING PRODUCTS & EQUIPMENT • NASDAQ

    $0.58
    -0.07 (-10.34%)

    Market Cap: $4.31M

    Last updated: Nov 17, 2026 at 4:32 PM ET

    Bio Green Med Solution, Inc. (BGMS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Bio Green Med Solution (BGMS) has a market cap of $4.31M and an enterprise value of $852.10K. Revenue grew 2658.02% over the last 12 months from the 12 months before. Its share count is up 246.29% from a year earlier.

    Total Valuation

    Enterprise value is 80.21% below the market cap, as cash exceeds debt.

    Market Cap$4.31M
    Enterprise Value$852.10K
    Latest price (Nov 17, 2026)$0.58

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 18.29% in the quarter ended Sep 30, 2026.

    Shares Outstanding6.62M
    Shares Change (YoY)+246.29%
    Shares Change (QoQ)+18.29%

    Valuation Ratios

    Sales and book value multiples are 1.7x and 0.6x. Its year-end P/S ranged from 7.9x to 21.4x from 2016 to 2025.

    P/S Ratio1.7x
    P/B Ratio0.6x
    P/TBV Ratio0.8x

    Valuation history and multiples

    Price Statistics

    The stock is down 55.50% over 52 weeks and trades 34.09% below its 50-day average.

    Beta (1Y)0.72
    52-Week Change-55.50%
    1-Month Change-37.51%
    3-Month Change-35.60%
    6-Month Change-39.33%
    5-Year Change-99.99%
    10-Year Change-100.00%
    Total Return (1Y)-55.50%
    Total Return (3Y CAGR)-90.71%
    Total Return (5Y CAGR)-85.88%
    Max Drawdown (1Y)-67.97%
    Max Drawdown (3Y)-99.92%
    Sharpe Ratio (1Y)-0.76
    Correlation with SPY (1Y)0.09
    50-Day Average$0.88
    200-Day Average$0.93
    52-Week Range$0.57 to $1.84
    RSI (14 Days)28.5
    Average Volume (20 Days)21.10K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.84x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.84x
    Quick Ratio5.63x
    Debt / Equity0.00x
    Interest Coverage16.09x

    Returns and Efficiency

    Return on equity is -24.95% and return on assets is -22.23% over the last 12 months.

    Return on Equity (ROE)-24.95%
    Return on Assets (ROA)-22.23%
    Asset Turnover0.29x
    Inventory Turnover1.81x
    Receivables Turnover2.18x
    Cash Conversion Cycle331 days

    Scores

    BGMS has an Altman Z-Score of -82.13, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-82.13
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $2.23M over the last 12 months.

    Revenue$2.23M
    Revenue Growth (YoY)+2658.02%
    Gross Profit$458.00K
    Operating Income-$2.27M
    Pretax Income-$1.61M
    Net Income-$1.66M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 89.04% of the $7.48M in total assets.

    Cash and Equivalents$3.45M
    Total Debt$0
    Net Cash$3.45M
    Net Cash Per Share$0.52
    Working Capital$4.76M
    Shareholder Equity$6.66M
    Book Value Per Share$1.01
    Tangible Book Value$5.09M
    Tangible Book Per Share$0.77
    Total Assets$7.48M
    Total Liabilities$817.00K

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$950.00K
    FCF Per Share-$0.14

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -101.43%.

    Gross Margin20.50%
    Operating Margin-101.43%
    Pretax Margin-72.29%
    Net Margin-74.40%

    Stock Splits

    The last split was a 1-for-15 reverse split on Jul 7, 2025.

    Last Split DateJul 7, 2025
    Split TypeReverse split
    Split Ratio1:15

    Peer Position

    Against 6 similar companies, BGMS has the 2nd highest P/S.

    P/S Ratio1.7x vs 0.8x median
    Revenue Growth (Trailing 4 Quarters, YoY)+2658.02% vs +31.82% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BGMS

    What is BGMS's market cap?

    Bio Green Med Solution has a market cap of $4.31M. Its enterprise value, which adds debt and subtracts cash, is $852.10K.

    How many shares of BGMS are outstanding?

    Bio Green Med Solution has 6.62M shares outstanding. The count is up 246.29% from a year earlier.

    Does BGMS pay a dividend?

    No. Bio Green Med Solution does not pay a dividend.

    How much debt does BGMS have?

    Bio Green Med Solution has $0 of total debt and $3.45M of cash and equivalents, a net cash position of $3.45M.